Diabetes

Cardiology

Obesity negates beneficial drug effects

Blocking CETP—a protein that shuttles cholesterol and triglycerides between lipoproteins such as HDL and LDL—has been shown to improve levels of the "good" cholesterol HDL. Outcomes from clinical trials of CETP inhibitors, ...

Diabetes

A novel insulin accelerant

Insulin levels rise after eating a meal, signaling uptake of circulating glucose by skeletal muscle. In individuals with diabetes this process is often impaired—a condition known as insulin resistance.

Diabetes

Targeting diabetic kidney disease

Diabetic nephropathy (DN) is a kidney disease characterized by loss of kidney function in patients with diabetes.

page 7 from 35